uterine fibroids Archives -

Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter’s once-daily oral therapy Ryeqo,

Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo

https://pharmaphorum.com/news/gedeon-richter-gets-nice-nod-for-uterine-fibroids-drug-ryeqo/

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in

ObsEva files uterine fibroid drug in US, chasing AbbVie, Myovant

https://pharmaphorum.com/news/obseva-filed-uterine-fibroid-drug-in-us-chasing-abbvie-myovant/

Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first

FDA clears Myovant’s relugolix for uterine fibroids, setting up AbbVie clash

https://pharmaphorum.com/news/fda-clears-myovants-relugolix-for-uterine-fibroids-setting-up-abbvie-clash/

AbbVie’s elagolix has shown promise in a phase 2 trial in women with uterine fibroids, a second indication for

AbbVie’s elagolix shows promise in uterine fibroids treatment

https://pharmaphorum.com/news/abbvies-elagloix-shows-promise-uterine-fibroids-treatment/

uterine fibroids